Biosimilar drugs are priced too high and do little to improve accessibility: Doctors

Biosimilar drugs are follow-on biologics that have nearly the same efficacy as the original drug and used to treat cancer or autoimmune diseases like rheumatoid arthritis.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news